- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
Meclizine Hydrochloride is a drug used to treat nausea, vomiting, and vertigo associated with motion sickness. It is also used to treat symptoms of vertigo caused by inner ear problems. In the context of oncology drugs, Meclizine Hydrochloride is used to treat the nausea and vomiting caused by chemotherapy and radiation therapy. It is also used to treat the vertigo caused by certain types of brain tumors. Meclizine Hydrochloride is available in tablet, capsule, and liquid form. It is usually taken orally, but can also be administered intravenously.
Some companies in the Meclizine Hydrochloride market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more